The data strongly indicated that only CIP2A (but not PP2A or c-MYC) is a reliable biomarker for detection of cervical cancer and furthermore there was no strong correlation of CIP2A expression with HPV subtype, age, ethnical background, or other patient characteristics. The gene discussed is CIP2A; the disease is cervical cancer.